+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Clinical Diagnostics Market - Global Forecast 2025-2030- Product Image
Clinical Diagnostics Market - Global Forecast 2025-2030- Product Image
Sale

Clinical Diagnostics Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 199 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5715761
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The clinical diagnostics market is evolving rapidly, underpinned by technological advancements and shifting regulatory, supply chain, and care delivery models. Industry decision-makers are tasked with navigating complex product offerings, regional challenges, and competitive dynamics as they pursue streamlined operations and sustainable growth.

Market Snapshot: Clinical Diagnostics Market Growth and Outlook

The clinical diagnostics market grew from USD 84.17 billion in 2024 to USD 91.68 billion in 2025. It is projected to sustain strong momentum with a CAGR of 8.67%, reaching USD 138.65 billion by 2030. This trajectory reflects the industry’s response to ongoing innovation in laboratory and point-of-care solutions, the integration of digital health capabilities, and rising global demand for efficient and accurate medical testing.

Scope & Segmentation

This report provides a comprehensive analysis of the clinical diagnostics landscape, highlighting key market segments, technologies, user groups, and regional trends.

  • Product Types: Instruments, reagents, and software/services, each supporting specific clinical workflows and diagnostic needs.
  • Technology Areas: Clinical chemistry, hematology, immunoassay, and molecular diagnostics, covering techniques including electrochemical and photometric assays, CBC analyzers, ELISA, CLIA, and next generation sequencing.
  • Applications: Cardiac care, diabetes monitoring, genetic testing, infectious disease detection, and oncology—addressing routine and specialized diagnostic demands.
  • End User Profiles: Academic research institutes, diagnostic laboratories, home care/self-testing settings, hospital laboratories, and clinics focused on point-of-care diagnostics.
  • Sample Types: Blood (plasma, serum, whole blood), saliva, urine, and tissue (biopsy, cytology) sources for comprehensive disease assessment.
  • Geographic Coverage: Americas, Europe, Middle East & Africa, Asia-Pacific, with detailed insights into country-level activity in the United States, Canada, China, India, Germany, and more.
  • Leading Companies: F. Hoffmann-La Roche Ltd, Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., bioMérieux SA, Becton, Dickinson and Company, Sysmex Corporation, Bio-Rad Laboratories, Inc., and QIAGEN N.V.

Key Takeaways for Senior Decision-Makers

  • Decentralization of diagnostics is accelerating, supporting point-of-care testing that empowers clinical teams and patients with timely, actionable insights outside traditional lab settings.
  • Strategic partnerships—especially those combining digital health and laboratory informatics—are redefining standards in diagnostic accuracy and operational efficiency.
  • Rapid innovation in molecular and immunoassay platforms is expanding the spectrum of detectable conditions, fostering growth in oncology, infectious disease, and genetic testing.
  • Service-oriented models that include consultation, training, and ongoing technical support are enhancing customer relationships and differentiating market leaders.
  • Adapting to regulatory shifts and digital transformation remains critical, as agencies increasingly emphasize compliant digital health technologies and agile market entry.

Tariff Impact and Supply Chain Considerations

Recent U.S. tariffs instituted in 2025 have increased costs for imported clinical diagnostic instruments and key reagents, compelling organizations to reassess sourcing and manufacturing strategies. Investment in localized production hubs and supply chain analytics has risen as businesses seek to ensure margin stability and timely delivery. Companies with lower tariff exposure or robust domestic operations are leveraging these shifts to strengthen competitive positioning across global markets.

Methodology & Data Sources

The report’s insights are founded on primary research with industry experts and secondary analysis of corporate disclosures, regulatory filings, patents, and market intelligence databases. Data triangulation, scenario analysis, and validation by advisory panels ensure that findings are robust and actionable for strategic planning.

Why This Report Matters

  • Gain a detailed, data-driven understanding of evolving market structures, enabling more effective investment and product development decisions.
  • Identify how technological integration and regulatory adaptation are shaping diagnostic strategies, informing proactive organizational planning.
  • Use competitive benchmarking and regional dynamics to refine market entry, partnership, and pricing strategies for sustained growth.

Conclusion

The clinical diagnostics market is shaped by a dynamic interplay of innovation, regulation, and global logistics. Strategic foresight, adaptation to emerging trends, and robust analytics will prove essential for executive leaders navigating this evolving landscape.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Emergence of artificial intelligence and machine learning algorithms for early disease detection and diagnostic accuracy improvements
5.2. Growing adoption of point-of-care molecular diagnostic devices for rapid infectious disease testing in decentralized settings
5.3. Integration of digital health platforms and telemedicine with remote diagnostic monitoring for chronic disease management
5.4. Expansion of liquid biopsy techniques for non-invasive cancer screening and personalized treatment monitoring
5.5. Development of CRISPR-based diagnostic assays enabling ultra-sensitive pathogen detection in resource-limited environments
5.6. Implementation of multiplexed immunoassays for simultaneous biomarker profiling in comprehensive diagnostic panels
5.7. Shift towards home-based diagnostic testing kits with smartphone connectivity for patient-centric healthcare delivery
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Clinical Diagnostics Market, by Product Type
8.1. Introduction
8.2. Instruments
8.2.1. Clinical Chemistry Analyzers
8.2.2. Hematology Analyzers
8.2.3. Immunoassay Analyzers
8.2.4. Molecular Diagnostics Instruments
8.3. Reagents
8.3.1. Clinical Chemistry Reagents
8.3.2. Hematology Reagents
8.3.3. Immunoassay Reagents
8.3.4. Molecular Diagnostics Reagents
8.4. Software & Services
8.4.1. Consultation & Support
8.4.2. Diagnostic Software
8.4.3. Lab Informatics
9. Clinical Diagnostics Market, by Technology
9.1. Introduction
9.2. Clinical Chemistry
9.2.1. Electrochemical Assays
9.2.2. Photometric Assays
9.3. Hematology
9.3.1. Cbc Analyzers
9.3.2. Coagulation Analyzers
9.4. Immunoassay
9.4.1. Clia
9.4.2. Elisa
9.4.3. Fia
9.5. Molecular Diagnostics
9.5.1. Isothermal Amplification
9.5.2. Next Generation Sequencing
9.5.3. Pcr
10. Clinical Diagnostics Market, by Application
10.1. Introduction
10.2. Cardiac Care
10.2.1. Lipid Profile
10.2.2. Troponin Testing
10.3. Diabetes
10.3.1. Glucose Monitoring
10.3.2. Hba1c Testing
10.4. Genetic Testing
10.4.1. Hereditary Disease Testing
10.4.2. Prenatal Newborn Screening
10.5. Infectious Diseases
10.5.1. Hepatitis
10.5.2. Hiv
10.5.3. Influenza
10.5.4. Malaria
10.6. Oncology
10.6.1. Biomarker Testing
10.6.2. Minimal Residual Disease
10.6.3. Tumor Profiling
11. Clinical Diagnostics Market, by End User
11.1. Introduction
11.2. Academic Research Institutes
11.3. Diagnostic Laboratories
11.4. Home Care
11.4.1. Self Testing
11.5. Hospital Laboratories
11.6. Point Of Care Testing
11.6.1. Clinics
11.6.2. Emergency Critical Care
12. Clinical Diagnostics Market, by Sample Type
12.1. Introduction
12.2. Blood
12.2.1. Plasma
12.2.2. Serum
12.2.3. Whole Blood
12.3. Saliva
12.4. Tissue
12.4.1. Biopsy
12.4.2. Cytology
12.5. Urine
13. Americas Clinical Diagnostics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Clinical Diagnostics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Clinical Diagnostics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. F. Hoffmann-La Roche Ltd
16.3.2. Abbott Laboratories
16.3.3. Danaher Corporation
16.3.4. Siemens Healthineers AG
16.3.5. Thermo Fisher Scientific Inc.
16.3.6. bioMérieux SA
16.3.7. Becton, Dickinson and Company
16.3.8. Sysmex Corporation
16.3.9. Bio-Rad Laboratories, Inc.
16.3.10. QIAGEN N.V.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. CLINICAL DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. CLINICAL DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. CLINICAL DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. CLINICAL DIAGNOSTICS MARKET: RESEARCHAI
FIGURE 26. CLINICAL DIAGNOSTICS MARKET: RESEARCHSTATISTICS
FIGURE 27. CLINICAL DIAGNOSTICS MARKET: RESEARCHCONTACTS
FIGURE 28. CLINICAL DIAGNOSTICS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. CLINICAL DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS REAGENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS REAGENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CONSULTATION & SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CONSULTATION & SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY LAB INFORMATICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY LAB INFORMATICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ELECTROCHEMICAL ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ELECTROCHEMICAL ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PHOTOMETRIC ASSAYS, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PHOTOMETRIC ASSAYS, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CBC ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CBC ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COAGULATION ANALYZERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY COAGULATION ANALYZERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ELISA, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY FIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY FIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ISOTHERMAL AMPLIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PCR, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY LIPID PROFILE, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TROPONIN TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TROPONIN TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GLUCOSE MONITORING, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HBA1C TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HBA1C TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEREDITARY DISEASE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEREDITARY DISEASE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRENATAL NEWBORN SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PRENATAL NEWBORN SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEPATITIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HEPATITIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HIV, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HIV, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INFLUENZA, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INFLUENZA, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MALARIA, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MALARIA, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BIOMARKER TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MINIMAL RESIDUAL DISEASE, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY MINIMAL RESIDUAL DISEASE, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TUMOR PROFILING, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SELF TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SELF TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY HOSPITAL LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY EMERGENCY CRITICAL CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY EMERGENCY CRITICAL CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PLASMA, BY REGION, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY PLASMA, BY REGION, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SERUM, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SERUM, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY SALIVA, BY REGION, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY BIOPSY, BY REGION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY CYTOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 173. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 174. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 175. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 176. GLOBAL CLINICAL DIAGNOSTICS MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 177. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 178. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 179. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 180. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 181. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 182. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 183. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 184. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 217. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 218. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 219. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 220. AMERICAS CLINICAL DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 221. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 222. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 223. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 224. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 225. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 226. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 227. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 228. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 229. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 230. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 262. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 263. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 264. UNITED STATES CLINICAL DIAGNOSTICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 265. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 266. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 267. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 268. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 269. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 270. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 271. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 272. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 273. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 274. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 275. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 276. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 277. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 278. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 279. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 280. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 281. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 282. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 283. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 284. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 285. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2018-2024 (USD MILLION)
TABLE 286. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2025-2030 (USD MILLION)
TABLE 287. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 288. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 289. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 290. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2025-2030 (USD MILLION)
TABLE 291. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2018-2024 (USD MILLION)
TABLE 292. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY INFECTIOUS DISEASES, 2025-2030 (USD MILLION)
TABLE 293. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
TABLE 294. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY ONCOLOGY, 2025-2030 (USD MILLION)
TABLE 295. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY HOME CARE, 2018-2024 (USD MILLION)
TABLE 298. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY HOME CARE, 2025-2030 (USD MILLION)
TABLE 299. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, 2018-2024 (USD MILLION)
TABLE 300. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY POINT OF CARE TESTING, 2025-2030 (USD MILLION)
TABLE 301. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 302. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 303. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, 2018-2024 (USD MILLION)
TABLE 304. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY BLOOD, 2025-2030 (USD MILLION)
TABLE 305. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, 2018-2024 (USD MILLION)
TABLE 306. CANADA CLINICAL DIAGNOSTICS MARKET SIZE, BY TISSUE, 2025-2030 (USD MILLION)
TABLE 307. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 308. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 309. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
TABLE 310. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, 2025-2030 (USD MILLION)
TABLE 311. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2018-2024 (USD MILLION)
TABLE 312. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY REAGENTS, 2025-2030 (USD MILLION)
TABLE 313. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2018-2024 (USD MILLION)
TABLE 314. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY SOFTWARE & SERVICES, 2025-2030 (USD MILLION)
TABLE 315. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 316. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 317. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2018-2024 (USD MILLION)
TABLE 318. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY CLINICAL CHEMISTRY, 2025-2030 (USD MILLION)
TABLE 319. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2018-2024 (USD MILLION)
TABLE 320. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY HEMATOLOGY, 2025-2030 (USD MILLION)
TABLE 321. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2018-2024 (USD MILLION)
TABLE 322. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY IMMUNOASSAY, 2025-2030 (USD MILLION)
TABLE 323. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2018-2024 (USD MILLION)
TABLE 324. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2025-2030 (USD MILLION)
TABLE 325. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 326. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 327. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2018-2024 (USD MILLION)
TABLE 328. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY CARDIAC CARE, 2025-2030 (USD MILLION)
TABLE 329. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2018-2024 (USD MILLION)
TABLE 330. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY DIABETES, 2025-2030 (USD MILLION)
TABLE 331. MEXICO CLINICAL DIAGNOSTICS MARKET SIZE, BY GENETIC TESTING, 2018-2024 (USD MILLION)
TABLE 332. MEXICO CLINICAL DIAGNOSTICS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Clinical Diagnostics market report include:
  • F. Hoffmann-La Roche Ltd
  • Abbott Laboratories
  • Danaher Corporation
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • bioMérieux SA
  • Becton, Dickinson and Company
  • Sysmex Corporation
  • Bio-Rad Laboratories, Inc.
  • QIAGEN N.V.

Table Information

Report AttributeDetails
No. of Pages199
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 91.68 Billion
Forecasted Market Value ( USD ) by 2030 $ 138.65 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Clinical Diagnostics Market Size, Share & Trends Analysis Report By Product (Instrument, Reagent), By Application (Infectious Disease, Oncology), By End Use (Hospitals & Clinics, Diagnostic Laboratory, Home Care Settings), By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Clinical Diagnostics Market Size, Share & Trends Analysis Report By Product (Instrument, Reagent), By Application (Infectious Disease, Oncology), By End Use (Hospitals & Clinics, Diagnostic Laboratory, Home Care Settings), By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 120 Pages
  • Global
From
Clinical Diagnostics Market Size, Share, Trends and Forecast by Test, Product, End User, and Region, 2025-2033 - Product Image

Clinical Diagnostics Market Size, Share, Trends and Forecast by Test, Product, End User, and Region, 2025-2033

  • Report
  • 141 Pages
  • Global
From
Clinical Diagnostic DNA Extractor Market - Global Forecast to 2030 - Product Image

Clinical Diagnostic DNA Extractor Market - Global Forecast to 2030

  • Report
  • 183 Pages
  • Global
From
Clinical Diagnostics Automation - Global Strategic Business Report - Product Image

Clinical Diagnostics Automation - Global Strategic Business Report

  • Report
  • 199 Pages
  • Global
From
Clinical Diagnostics Market Report 2025 - Product Image

Clinical Diagnostics Market Report 2025

  • Report
  • 200 Pages
  • Global
From

About the Market

The Clinical Diagnostics market is a segment of the Diagnostics industry that focuses on the diagnosis and treatment of diseases and medical conditions. It includes a wide range of tests and procedures used to detect, diagnose, and monitor diseases and medical conditions. These tests are used to identify the presence of a disease or condition, to determine the cause of a disease or condition, and to monitor the progress of a disease or condition. Clinical Diagnostics tests are used to diagnose and monitor a variety of diseases and medical conditions, including cancer, cardiovascular disease, infectious diseases, and genetic disorders. The Clinical Diagnostics market is highly competitive, with a number of companies offering a wide range of products and services. Some of the major players in the market include Abbott Laboratories, Becton Dickinson, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.